V

Verily

1459 employees

Verily develops tools and devices to collect and analyze health data to research and manage diseases.

Investor insights

Sectors invested in

Biotechnology12
Health Care10
Health Diagnostics4
Cloud Data Services3
Industrial Automation3
Robotics3
Software3
Personal Health3
Pharmaceutical3
Medical3
machine learning3
SaaS2
Life Science2
computational biology2
early cancer detection2
multiomics2
oncology2
biotechnology2
cancer screening2
molecular diagnostics2

Funding rounds participated in

$45M sweet spot round size

Most of their 16 investments are in rounds between $8M and $80M

Basic info

Industry

biotechnology research
hospitals and health care

Sectors

scientific research
software
health tech
health equity
disease management platforms
precision health
Analytics
healthcare
Enterprise Software
Health Care
digital health
sensors
population health management
clinical studies
precision medicine
hardware
Information Technology

Date founded

2015

Investments made

T

The Public Health Company raised $35M on May 1, 2022

Investors: Venrock, ImpactAssets, The General Partnership and Verily

S

Syllable raised $40M on February 7, 2022

Investors: Oak HC/FT, TCV, Section 32 and Verily

E

EQRx raised $1.2B on December 17, 2021

Investors: The Invus Group, Corvex Connected Worker™, Casdin Capital, LLC and Verily

C

Culture Biosciences raised $80M on October 14, 2021

Investors: Cultivian Sandbox Ventures, BoxGroup, GRIDS Capital, Craft Ventures, The Production Board, Northpond Ventures, Synthesis Capital, Section 32 and Verily

M

Marvin raised $6.2M on May 11, 2021

Investors: Verily

T

The Public Health Company raised $8M on April 29, 2021

Investors: Sweat Equity Ventures, Venrock and Verily

G

Genalyte, Inc. raised $50M on January 11, 2021

Investors: Provenio Capital, Samsara BioCapital, Khosla Ventures, Redmile Group and Verily

C

Culture Biosciences raised $15M on March 4, 2020

Investors: Data Collective, Sandbox Industries, Craft Ventures, The Production Board, Section 32, Y Combinator, Cultivian Sandbox Ventures and Verily

M

Mammoth Biosciences raised $45M on January 30, 2020

Investors: Decheng Capital, Pacific 8 Ventures, Mayfield Fund, Plum Alley Investments, aMoon Fund and Verily

F

Freenome raised $160M on July 24, 2019

Investors: T. Rowe Price, RA Capital Management, L.P., Polaris Partners, Longevity Vision Fund, Soleus Capital Management, L.P., Perceptive Advisors, Section 32 and Verily

FAQ